IMUX ▲ +3.2% - Immunic, Inc. $IMUX IMUX - Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 Immunic announced it will host a virtual R&D day focused on relapsing multiple sclerosis on September 9, 2026, driving shares up 3.2% today. The event signals the company's continued pipeline progress in a key therapeutic area and offers investors and analysts a chance to learn more about its development strategy and clinical data. 02-SEP-2026 06:30 AM ET